Using the IVW method, we found that TLR4 levels were associated with the risk of hemolysis in patients with AML, with an odds ratio of 1.013 (95% confidence interval = 1.001–1.045, p = 0.031216). Here, TLR4 is linked to acute myeloid leukemia.